These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 27014912)
1. From kinetics and cellular cooperations to cancer immunotherapies. Trautmann A Oncotarget; 2016 Jul; 7(28):44779-44789. PubMed ID: 27014912 [TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanisms of tumor and immune system interaction]. Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839 [No Abstract] [Full Text] [Related]
3. The Contribution of the Immune System in Bone Metastasis Pathogenesis. Xiang L; Gilkes DM Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823602 [TBL] [Abstract][Full Text] [Related]
4. Tumour immunotherapy--leukocytes take up the fight. Alderton GK; Bordon Y Nat Rev Immunol; 2012 Apr; 12(4):237. PubMed ID: 22545289 [TBL] [Abstract][Full Text] [Related]
5. The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. Zhang Q; Zhang S; Chen J; Xie Z Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047140 [TBL] [Abstract][Full Text] [Related]
6. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. Dougall WC; Kurtulus S; Smyth MJ; Anderson AC Immunol Rev; 2017 Mar; 276(1):112-120. PubMed ID: 28258695 [TBL] [Abstract][Full Text] [Related]
7. Ethical considerations of cellular immunotherapy for cancer. Ren SS; Deng JW; Hong M; Ren YL; Fu HJ; Liu YN; Chen Z J Zhejiang Univ Sci B; 2019 Jan.; 20(1):23-31. PubMed ID: 30614227 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-derived exosomes for cancer therapy. Pitt JM; André F; Amigorena S; Soria JC; Eggermont A; Kroemer G; Zitvogel L J Clin Invest; 2016 Apr; 126(4):1224-32. PubMed ID: 27035813 [TBL] [Abstract][Full Text] [Related]
10. NK cell receptors as tools in cancer immunotherapy. Sentman CL; Barber MA; Barber A; Zhang T Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660 [TBL] [Abstract][Full Text] [Related]
11. Adoptive cellular immunotherapy of cancer. Winter H; Fox BA Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690 [No Abstract] [Full Text] [Related]
14. The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapies. Dosani T; Carlsten M; Maric I; Landgren O Blood Cancer J; 2015 Apr; 5(4):e306. PubMed ID: 25885426 [TBL] [Abstract][Full Text] [Related]
15. [Cellular immune mechanism against cancer cells and immunotherapy of cancer]. Kikuchi K Nihon Hinyokika Gakkai Zasshi; 1990; 81(13 Suppl):1977. PubMed ID: 2131367 [No Abstract] [Full Text] [Related]
17. New cancer-fighting cells enter trials. Leslie M Science; 2018 Sep; 361(6407):1056-1057. PubMed ID: 30213892 [No Abstract] [Full Text] [Related]
18. Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector. Quinn M; Erkes DA; Snyder CM Immunotherapy; 2016 Feb; 8(2):211-21. PubMed ID: 26786895 [TBL] [Abstract][Full Text] [Related]
19. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880 [TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironments, the immune system and cancer survival. Strausberg RL Genome Biol; 2005; 6(3):211. PubMed ID: 15774034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]